Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael G Robson

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Nephron. Experimental Nephrology|July 11, 2009
Toll-like receptors and renal diseaseMichael G Robson
Nephron. Clinical Practice|November 22, 2014
Complement and glomerular diseasesReena J Popat, Michael G Robson
Current Opinion in Nephrology and Hypertension|October 6, 2005
RNA interference--a new experimental and therapeutic toolMichael G Robson, Steven H Sacks
Annals of the Rheumatic Diseases|December 6, 2018
Neutrophils are not consistently activated by antineutrophil cytoplasmic antibodies in vitroReena J Popat, Michael G Robson
Kidney International|May 30, 2008
Arteriovenous fistula in the rat tail: a new model of hemodialysis access dysfunctionTao Lin, Catherine Horsfield, Michael G Robson
Scientific Reports|October 26, 2023
Author Correction: Circulating Interleukin-6 and CD16 positive monocytes increase following angioplasty of an arteriovenous fistulaSeran Hakki, Emily J Robinson, Michael G Robson
Kidney International|July 23, 2021
The authors replyNarayan Karunanithy, Emily J Robinson, Michael G Robson
Scientific Reports|January 27, 2022
Circulating Interleukin-6 and CD16 positive monocytes increase following angioplasty of an arteriovenous fistulaSeran Hakki, Emily J Robinson, Michael G Robson
Scientific Reports|November 1, 2022
Author Correction: Circulating Interleukin‑6 and CD16 positive monocytes increase following angioplasty of an arteriovenous fistulaSeran Hakki, Emily J Robinson, Michael G Robson
American Journal of Physiology. Renal Physiology|August 10, 2006
Rapamycin at subimmunosuppressive levels inhibits mesangial cell proliferation and extracellular matrix productionHelen R Lock, Steven H Sacks, Michael G Robson
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Nephron. Experimental Nephrology|July 11, 2009
Toll-like receptors and renal diseaseMichael G Robson
Nephron. Clinical Practice|November 22, 2014
Complement and glomerular diseasesReena J Popat, Michael G Robson
Current Opinion in Nephrology and Hypertension|October 6, 2005
RNA interference--a new experimental and therapeutic toolMichael G Robson, Steven H Sacks
Annals of the Rheumatic Diseases|December 6, 2018
Neutrophils are not consistently activated by antineutrophil cytoplasmic antibodies in vitroReena J Popat, Michael G Robson
Kidney International|May 30, 2008
Arteriovenous fistula in the rat tail: a new model of hemodialysis access dysfunctionTao Lin, Catherine Horsfield, Michael G Robson
Scientific Reports|October 26, 2023
Author Correction: Circulating Interleukin-6 and CD16 positive monocytes increase following angioplasty of an arteriovenous fistulaSeran Hakki, Emily J Robinson, Michael G Robson
Kidney International|July 23, 2021
The authors replyNarayan Karunanithy, Emily J Robinson, Michael G Robson
Scientific Reports|January 27, 2022
Circulating Interleukin-6 and CD16 positive monocytes increase following angioplasty of an arteriovenous fistulaSeran Hakki, Emily J Robinson, Michael G Robson
Scientific Reports|November 1, 2022
Author Correction: Circulating Interleukin‑6 and CD16 positive monocytes increase following angioplasty of an arteriovenous fistulaSeran Hakki, Emily J Robinson, Michael G Robson
American Journal of Physiology. Renal Physiology|August 10, 2006
Rapamycin at subimmunosuppressive levels inhibits mesangial cell proliferation and extracellular matrix productionHelen R Lock, Steven H Sacks, Michael G Robson
Pageof 5